Compass Pathways may be the first to benefit from an accelerated approval process.
Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...
Before we talk about Rocket and Compass, we need to talk about OriginPoint. In 2021, Compass and then Guaranteed Rate (now Rate) announced the formation of OriginPoint, a joint venture mortgage ...
The Consumer Policy Center estimated that Compass’ market share was up to 40 percent after its deal for Anywhere Real Estate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results